All analyses
AI analysis

Janashakthi Insurance Company PLC: research report

Moderately undervaluedbearishNov 17, 2026

The evidence points bearish because September-quarter profit fell 98.1% and the margin collapsed. The counterweight is a moderately undervalued market-wide score of 63.

Reports without a focus are public, one per stock per day. Generation usually takes about 15 minutes, and we'll notify you when it's ready.

Why bearish

  • September-quarter net profit fell 98.1% year-on-year to LKR 29 million, leaving only a 1.0% net margin.
  • The share trades at 32.9 rupees for every rupee of trailing profit, while the latest quarter earned at a far weaker margin than a year earlier.

Against this. It scores 63 of 100 on price against book value, earnings and dividends, placing it in the moderately undervalued band.

Net margin
1.0%sector 1.4%
from 34.3% a year earlier, revenue -30.4%
Return on equity
4.7%
twelve months to Sep 30, 2026, unaudited
P/E
32.9sector 15.6
earnings Rs 1.16 per share, year to Sep 2026
P/B
1.54sector 1.46
book Rs 24.73 per share
Dividend yield
8.77%sector 1.83%
288.3% of earnings paid out

Current figures, updated daily from filings to Sep 30, 2026. The report below was written on Nov 17, 2026. Sector figures are the median of 11 listed companies in the same sector.

Overview

Janashakthi Insurance is a Sri Lankan life and health insurer, earning from underwriting, renewals, claims administration and its investment portfolio. The central change is a sharp weakening in reported quarterly profitability despite continued premium growth reported for the nine months to September.

Price performance

At LKR 38.00 on 17 November 2026, JINS was down 10.8% over three months while the ASPI gained 1.0%, and was down 29.6% over one year against the index's 7.7% fall. The April 2026 one-for-three split tripled the share count, so these returns are restated onto today's share basis and do not confuse the split with investment performance.

The share sits 26.2% through its 52-week range, 30.8% below its high. Recent volatility was 9.0% above its own one-year norm and 20-day volume was 62.8% above the 60-day norm, showing trading has become busier than this share's usual pattern.

The record shows four falls of 15% or more in three years, the deepest 42%, which has not yet recovered. Liquidity is limited: median daily turnover was LKR 1.2 million, and a LKR 1 million order is about 82% of what trades on a typical day, a large part of a day's trading.

Valuation

The trailing P/E is 32.9, meaning LKR 32.9 is paid for every LKR 1 of profit over the twelve months to September 2026. That is at the 71st percentile among insurance peers with usable earnings multiples, placing it above much of the sector on this measure despite the recent profit contraction.

The P/B is 1.54, or LKR 1.54 for each LKR 1 of net assets, while trailing ROE is 4.7%. Its P/B is more expensive than 68% of days since January 2019, so the current book-value multiple is high against the company's own record. The 8.8% dividend yield is supported by a payout that rose between 2023 and 2025, but the latest trailing payout exceeds earnings, making the yield dependent on more than current profit generation.

A buyer at this price is relying on a recovery from the latest quarter's 1.0% net margin: at the year-ago margin, the same price would equate to a P/E of 14.9 rather than the current multiple.

News and sentiment

Company coverage was normal over the past 90 days, with five material articles split between two positive, two negative and one neutral item. The directly relevant updates reported nine-month gross written premiums of LKR 7.4 billion, up 21%, and profit before tax of LKR 391 million on 16 November; lower investment income and mark-to-market losses were cited as the profitability drag.

A 17 November negative article concerns Janashakthi PLC, JXG, rather than JINS and is not evidence about this insurer. The confirmed one-for-three share subdivision took effect on 9 April 2026; it changed per-share presentation but not the size of the underlying insurer.

Financials

September-quarter revenue fell 30.4% year-on-year and net profit fell 98.1%, leaving LKR 29 million for shareholders. The profit a share represents therefore contracted far faster than the income line.

Gross and operating margins are unavailable in both the latest and year-ago interim data. Net margin fell from 34.3% to 1.0%, meaning the company retained about one cent from each rupee of quarterly revenue versus 34 cents a year earlier; this was among its worst September outcomes, ranking sixth of seven comparable September quarters.

Equity was lower year-on-year. The reported share count is now three times the pre-split count following the April subdivision, so the decline in EPS and net assets per share across that date is partly mechanical and should be judged primarily from absolute profit and equity.

Risks

The foremost risk is weak and volatile investment-linked profitability. The September quarter produced a 1.0% net margin after a 34.3% margin a year earlier, while the company's November results update cited lower investment income and mark-to-market losses from policy-rate changes. This makes current earnings less robust than the trailing dividend yield suggests.

The trailing dividend payout was 288.3% of earnings and dividend cover was only 0.35 times, meaning reported profit covered only a fraction of the distribution. For an insurer, liabilities relative to equity rose to 1.43 times at December 2025 from 1.24 times a year earlier, increasing the importance of preserving capital and investment values.

Outlook

As at 17 November 2026, the next scheduled catalyst is the audited year to December 2026, expected to be filed between 28 April and 3 June 2027. It will determine whether premium growth and the reported LKR 391 million nine-month profit before tax translate into a durable recovery in shareholder earnings, or whether investment valuation losses continue to restrain results.

Falling government bond yields are relevant to the insurance sector's fixed-income portfolios, but this data cannot determine Janashakthi's portfolio positioning or the eventual effect on its earnings. The annual filing is therefore the next evidence that can resolve the gap between growing premiums and the very weak September-quarter margin.

About this report. Generated on Nov 17, 2026 from market data up to Nov 17, 2026, 5 material news articles over 90 days and financials to Sep 30, 2026, and scored 63 of 100 on value (moderately undervalued) when it was written. Every figure is drawn from EquityLK's own data on this company. AI research can contain errors, so treat it as a starting point, not investment advice.

Previous reports